KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (KALV)

CUSIP: 483497103

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
50,580,036
Total 13F shares
23,784,064
Share change
-1,115,603
Total reported value
$314,614,009
Put/Call ratio
84%
Price per share
$13.23
Number of holders
93
Value change
-$24,155,895
Number of buys
42
Number of sells
49

Quarterly Holders Quick Answers

What is CUSIP 483497103?
CUSIP 483497103 identifies KALV - KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (KALV) as of Q4 2021

As of 31 Dec 2021, KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (KALV) was held by 93 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 23,784,064 shares. The largest 10 holders included RA CAPITAL MANAGEMENT, L.P., WELLINGTON MANAGEMENT GROUP LLP, SUVRETTA CAPITAL MANAGEMENT, LLC, Vivo Capital, LLC, BlackRock Inc., Deep Track Capital, LP, FRAZIER MANAGEMENT LLC, FRANKLIN RESOURCES INC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), and VANGUARD GROUP INC. This page lists 93 institutional shareholders reporting positions in this security for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.